Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 40
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Parasitol Res ; 123(2): 138, 2024 Feb 21.
Artículo en Inglés | MEDLINE | ID: mdl-38378851

RESUMEN

The parasite Entamoeba histolytica is the cause of amoebic dysentery and liver abscess in humans. On the protozoan cell surface, a variety of glycosylated molecules are involved in the interaction with the environment, such as attachment to the colonic mucus. One of these molecules is the lipopeptidophosphoglycan (LPPG), a complex surface component with antigenic properties. Its structure is only partly known, it is a glycosylphosphatidylinositol (GPI)-linked glycoprotein with a large amount of O-glycosylation. To date, the sequence of a core protein has not been identified. In this study, we further investigated this complex surface molecule aided by the availability of the monoclonal antibody EH5, which had been raised in our laboratory. We studied the extraction of LPPG in various solvent mixtures and discovered that 2-butanol saturated water was simple and superior to other solvents used in the past. The isolated LPPG was subjected to treatment with several proteases and the Ser/Thr specific cleavage agent scandium (III) trifluoromethanesulfonate (scandium triflate). The products were probed with antibody EH5 and the blots showed that the LPPG preparation was largely resistant to standard proteases, but could be cleaved by the scandium compound. These observations could point to the existence of a Ser- or Thr-rich core protein structure.


Asunto(s)
Entamoeba histolytica , Entamoeba , Peptidoglicano , Fosfolípidos , Humanos , Escandio , Antígenos de Protozoos , Péptido Hidrolasas
2.
Mol Microbiol ; 91(1): 198-208, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24256032

RESUMEN

The enzyme flavin reductase 1 (FR1) from Trichomonas vaginalis, formerly known as NADPH oxidase, was isolated and identified. Flavin reductase is part of the antioxidative defence in T. vaginalis and indirectly reduces molecular oxygen to hydrogen peroxide via free flavins. Importantly, a reduced or absent flavin reductase activity has been reported in metronidazole-resistant T. vaginalis, resulting in elevated intracellular oxygen levels and futile cycling of metronidazole. Interestingly, FR1 has no close homologue in any other sequenced genome, but seven full-length and three truncated isoforms exist in the T. vaginalis genome. However, out of these, only FR1 has an affinity for flavins, i.e. FMN, FAD and riboflavin, which is high enough to be of physiological relevance. Although there are no relevant changes in the gene sequence or any alterations of the predicted FR1-mRNA structure in any of the strains studied, FR1 is not expressed in highly metronidazole-resistant strains. Transfection of a metronidazole-resistant clinical isolate (B7268), which does not express any detectable amounts of FR, with a plasmid bearing a functional FR1 gene nearly completely restored metronidazole sensitivity. Our results indicate that FR1 has a significant role in the emergence of metronidazole resistance in T. vaginalis.


Asunto(s)
Antiprotozoarios/farmacología , Resistencia a Medicamentos/genética , FMN Reductasa/metabolismo , Flavinas/metabolismo , Peróxido de Hidrógeno/metabolismo , Metronidazol/farmacología , Trichomonas vaginalis/enzimología , FMN Reductasa/genética , Genes Protozoarios , Isoformas de Proteínas/metabolismo , Trichomonas vaginalis/genética , Trichomonas vaginalis/aislamiento & purificación
3.
Parasitol Res ; 114(5): 1939-47, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25700717

RESUMEN

Entamoeba histolytica is the causative agent of amoebic dysentery and liver abscess. The medium for its axenic culture contains glucose as energy source, and we addressed the question whether E. histolytica can also use fructose instead. As the amoebic hexokinases do not phosphorylate fructose, a separate fructokinase is essential. The genome project revealed a single candidate gene encoding an E. histolytica homolog of bacterial fructokinases. This gene was cloned, and the recombinant enzyme had a magnesium-dependent fructose 6-kinase activity (EC 2.7.1.4) with a K m for fructose of 0.156 mM and a V max of 131 U/mg protein. Recombinant fructokinase also showed a much weaker mannokinase activity, but no activity with glucose or galactose. The amoebae could be switched from glucose to fructose medium without any detectable consequence on doubling time. Fructokinase messenger RNA (mRNA) was modestly but significantly upregulated in amoebae switched to fructose medium as well as in fructose-adapted E. histolytica.


Asunto(s)
Entamoeba histolytica/enzimología , Fructoquinasas/metabolismo , Regulación Enzimológica de la Expresión Génica/fisiología , Entamoeba histolytica/genética , Fructoquinasas/genética , Fructosa/metabolismo , Glucosa/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Regulación hacia Arriba
4.
Biochem J ; 451(2): 277-88, 2013 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-23398389

RESUMEN

Entamoeba histolytica, the causative agent of amoebiasis, possesses the dithiol-containing redox proteins Trx (thioredoxin) and TrxR (Trx reductase). Both proteins were found to be covalently modified and inactivated by metronidazole, a 5-nitroimidazole drug that is commonly used to treat infections with microaerophilic protozoan parasites in humans. Currently, very little is known about enzymes and other proteins participating in the Trx-dependent redox network of the parasite that could be indirectly affected by metronidazole treatment. On the basis of the disulfide/dithiol-exchange mechanism we constructed an active-site mutant of Trx, capable of binding interacting proteins as a stable mixed disulfide intermediate to screen the target proteome of Trx in E. histolytica. By applying Trx affinity chromatography, two-dimensional gel electrophoresis and MS, peroxiredoxin and 15 further potentially redox-regulated proteins were identified. Among them, EhSat1 (E. histolytica serine acetyltransferase-1), an enzyme involved in the L-cysteine biosynthetic pathway, was selected for detailed analysis. Binding of Trx to EhSat1 was verified by Far-Western blot analysis. Trx was able to restore the activity of the oxidatively damaged EhSat1 suggesting that the TrxR/Trx system protects sensitive proteins against oxidative stress in E. histolytica. Furthermore, the activity of peroxiredoxin, which is dependent on a functioning TrxR/Trx system, was strongly reduced in metronidazole-treated parasites.


Asunto(s)
Entamoeba histolytica/enzimología , Proteínas Protozoarias/metabolismo , Serina O-Acetiltransferasa/metabolismo , Tiorredoxinas/metabolismo , Antiprotozoarios/farmacología , Western Blotting , Dominio Catalítico , Cromatografía de Afinidad , Disulfuros/química , Disulfuros/metabolismo , Electroforesis en Gel Bidimensional , Entamoeba histolytica/efectos de los fármacos , Espectrometría de Masas , Metronidazol/farmacología , Mutación , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , Peroxirredoxinas/metabolismo , Proteínas Protozoarias/genética , Serina O-Acetiltransferasa/genética , Reductasa de Tiorredoxina-Disulfuro/metabolismo , Tiorredoxinas/genética
5.
Exp Parasitol ; 134(3): 374-80, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23578856

RESUMEN

Our previous observation that NADP-dependent secondary alcohol dehydrogenase (ADH-1) is down-regulated in metronidazole-resistant Trichomonas vaginalis isolates prompted us to further characterise the enzyme. In addition to its canonical enzyme activity as a secondary alcohol dehydrogenase, a pronounced, so far unknown, background NADPH-oxidising activity in absence of any added substrate was observed when the recombinant enzyme or T. vaginalis extract were used. This activity was strongly enhanced at low oxygen concentrations. Unexpectedly, all functions of ADH-1 were efficiently inhibited by coenzyme A which is a cofactor of a number of key enzymes in T. vaginalis metabolism, i.e. pyruvate:ferredoxin oxidoreductase (PFOR). These observations could be extended to Entamoeba histolytica and Tritrichomonas foetus, both of which have a homologue of ADH-1, but not to Giardia lamblia which lacks an NADP-dependent secondary alcohol dehydrogenase. Although we could not identify the substrate of the observed background activity, we propose that ADH-1 functions as a major sink for NADPH in microaerophilic parasites at low oxygen tension.


Asunto(s)
Oxidorreductasas de Alcohol/metabolismo , Entamoeba histolytica/enzimología , Trichomonas vaginalis/enzimología , Tritrichomonas foetus/enzimología , 2-Propanol/metabolismo , 2-Propanol/farmacología , Acetaldehído/metabolismo , Acetona/metabolismo , Oxidorreductasas de Alcohol/antagonistas & inhibidores , Oxidorreductasas de Alcohol/genética , Coenzima A/farmacología , ADN Protozoario/genética , Entamoeba histolytica/genética , Regulación Enzimológica de la Expresión Génica , Giardia lamblia/enzimología , Giardia lamblia/genética , Concentración de Iones de Hidrógeno , Concentración 50 Inhibidora , Cinética , NADP/metabolismo , Oxidación-Reducción , Proteínas Recombinantes/antagonistas & inhibidores , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Especificidad por Sustrato , Trichomonas vaginalis/genética , Tritrichomonas foetus/genética
6.
PLoS Negl Trop Dis ; 17(8): e0011574, 2023 08.
Artículo en Inglés | MEDLINE | ID: mdl-37616327

RESUMEN

In the human host, the protozoan parasite Entamoeba histolytica is adapted to a non-invasive lifestyle in the colon as well as to an invasive lifestyle in the mesenterial blood vessels and the liver. This means to cope with bacteria and human cells as well as various metabolic challenges. Galactose and N-acetylgalactosamine (GalNAc) are sugars of great importance for the amoebae, they attach to the host mucus and enterocytes via their well-studied Gal/GalNAc specific lectin, they carry galactose residues in their surface glycans, and they cleave GalNAc from host mucins. The enzyme UDP-glucose 4-epimerase (GalE) works as a bridge between the galactose and glucose worlds, it can help to generate glucose for glycolysis from phagocytosis products containing galactose as well as providing UDP-galactose necessary for the biosynthesis of galactose-containing surface components. E. histolytica contains a single galE gene. We recombinantly expressed the enzyme in Escherichia coli and used a spectrophotometric assay to determine its temperature and pH dependency (37°C, pH 8.5), its kinetics for UDP-glucose (Km = 31.82 µM, Vmax = 4.31 U/mg) and substrate spectrum. As observed via RP-HPLC, the enzyme acts on UDP-Glc/Gal as well as UDP-GlcNAc/GalNAc. Previously, Trypanosoma brucei GalE and the bloodstream form of the parasite were shown to be susceptible to the three compounds ebselen, a selenoorganic drug with antioxidant properties, diethylstilbestrol, a mimic of oestrogen with anti-inflammatory properties, and ethacrynic acid, a loop diuretic used to treat oedema. In this study, the three compounds had cytotoxic activity against E. histolytica, but only ebselen inhibited the recombinant GalE with an IC50 of 1.79 µM (UDP-Gal) and 1.2 µM (UDP-GalNAc), suggesting that the two other compounds are active against other targets in the parasite. The importance of the ability of GalE to interconvert UDP-GalNAc and UDP-GlcNAc may be that the trophozoites can generate precursors for their own cyst wall from the sugar subunits cleaved from host mucins. This finding advances our understanding of the biochemical interactions of E. histolytica in its colonic environment.


Asunto(s)
Quistes , Entamoeba histolytica , Humanos , UDPglucosa 4-Epimerasa , Galactosa , Glucosa , Acetilgalactosamina , Uridina Difosfato
7.
J Antimicrob Chemother ; 66(8): 1756-65, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21602576

RESUMEN

OBJECTIVES: The mechanism of action of, and resistance to, metronidazole in the anaerobic (or micro-aerotolerant) protozoan parasite Giardia lamblia has long been associated with the reduction of ferredoxin (Fd) by the enzyme pyruvate:ferredoxin oxidoreductase (PFOR) and the subsequent activation of metronidazole by Fd to toxic radical species. Resistance to metronidazole has been associated with down-regulation of PFOR and Fd. The aim of this study was to determine whether the PFOR/Fd couple is the only pathway involved in metronidazole activation in Giardia. METHODS: PFOR and Fd activities were measured in extracts of highly metronidazole-resistant (MTR(r)) lines and activities of recombinant G. lamblia thioredoxin reductase (GlTrxR) and NADPH oxidase were assessed for their involvement in metronidazole activation and resistance. RESULTS: We demonstrated that several lines of highly MTR(r) G. lamblia have fully functional PFOR and Fd indicating that PFOR/Fd-independent mechanisms are involved in metronidazole activation and resistance in these cells. Flavin-dependent GlTrxR, like TrxR of other anaerobic protozoa, reduces 5-nitroimidazole compounds including metronidazole, although expression of TrxR is not decreased in MTR(r) Giardia. However, reduction of flavins is suppressed in highly MTR(r) cells, as evidenced by as much as an 80% decrease in NADPH oxidase flavin mononucleotide reduction activity. This suppression is consistent with generalized impaired flavin metabolism in highly MTR(r) Trichomonas vaginalis. CONCLUSIONS: These data add to the mounting evidence against the dogma that PFOR/Fd is the only couple with a low enough redox potential to reduce metronidazole in anaerobes and point to the multi-factorial nature of metronidazole resistance.


Asunto(s)
Resistencia a Medicamentos , Flavinas/metabolismo , Giardia lamblia/efectos de los fármacos , Giardia lamblia/metabolismo , Nitroimidazoles/metabolismo , Piruvato-Sintasa/metabolismo , Reductasa de Tiorredoxina-Disulfuro/metabolismo , Antiprotozoarios/metabolismo , Humanos , Metabolismo
8.
Nature ; 433(7028): 865-8, 2005 Feb 24.
Artículo en Inglés | MEDLINE | ID: mdl-15729342

RESUMEN

Entamoeba histolytica is an intestinal parasite and the causative agent of amoebiasis, which is a significant source of morbidity and mortality in developing countries. Here we present the genome of E. histolytica, which reveals a variety of metabolic adaptations shared with two other amitochondrial protist pathogens: Giardia lamblia and Trichomonas vaginalis. These adaptations include reduction or elimination of most mitochondrial metabolic pathways and the use of oxidative stress enzymes generally associated with anaerobic prokaryotes. Phylogenomic analysis identifies evidence for lateral gene transfer of bacterial genes into the E. histolytica genome, the effects of which centre on expanding aspects of E. histolytica's metabolic repertoire. The presence of these genes and the potential for novel metabolic pathways in E. histolytica may allow for the development of new chemotherapeutic agents. The genome encodes a large number of novel receptor kinases and contains expansions of a variety of gene families, including those associated with virulence. Additional genome features include an abundance of tandemly repeated transfer-RNA-containing arrays, which may have a structural function in the genome. Analysis of the genome provides new insights into the workings and genome evolution of a major human pathogen.


Asunto(s)
Entamoeba histolytica/genética , Genoma de Protozoos , Parásitos/genética , Animales , Entamoeba histolytica/metabolismo , Entamoeba histolytica/patogenicidad , Evolución Molecular , Fermentación , Transferencia de Gen Horizontal/genética , Glucólisis , Estrés Oxidativo/genética , Parásitos/metabolismo , Parásitos/patogenicidad , Filogenia , Transducción de Señal , Virulencia/genética
9.
Eukaryot Cell ; 9(4): 611-8, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20190073

RESUMEN

Acanthamoeba castellanii is a facultative pathogen that has a two-stage life cycle comprising the vegetatively growing trophozoite stage and the dormant cyst stage. Cysts are formed when the cell encounters unfavorable conditions, such as environmental stress or food deprivation. Due to their rigid double-layered wall, Acanthamoeba cysts are highly resistant to antiamoebic drugs. This is problematic as cysts can survive initially successful chemotherapeutic treatment and cause relapse of the disease. We studied the Acanthamoeba encystment process by using two-dimensional gel electrophoresis (2DE) and found that most changes in the protein content occur early in the process. Truncated actin isoforms were found to abound in the encysting cell, and the levels of translation elongation factor 2 (EF2) were sharply decreased, indicating that the rate of protein synthesis must be low at this stage. In the advanced stage of encystment, however, EF2 levels and the trophozoite proteome were partly restored. The protease inhibitors PMSF (phenylmethylsulfonyl fluoride) and E64d [(2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester] inhibited the onset of encystment, whereas the protein synthesis inhibitor cycloheximide was ineffective. Changes in the protein profile, similar to those of encysting cells, could be observed with trophozoite homogenates incubated at room temperature for several hours. Interestingly, these changes could be inhibited significantly by cysteine protease inhibitors but not by inhibitors against other proteases. Taken together, we conclude that the encystment process in A. castellanii is of a bipartite nature consisting of an initial phase of autolysis and protein degradation and an advanced stage of restoration accompanied by the expression of encystment-specific genes.


Asunto(s)
Acanthamoeba castellanii/enzimología , Acanthamoeba castellanii/fisiología , Proteasas de Cisteína/metabolismo , Estadios del Ciclo de Vida , Proteínas Protozoarias/química , Acanthamoeba castellanii/citología , Acanthamoeba castellanii/patogenicidad , Amebiasis/patología , Animales , Inhibidores de Cisteína Proteinasa/metabolismo , Electroforesis en Gel Bidimensional , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , Trofozoítos/citología , Trofozoítos/enzimología , Trofozoítos/fisiología
10.
Allergy Asthma Immunol Res ; 13(1): 154-163, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33191683

RESUMEN

Arginine kinase (AK) was first identified as an allergen in the Indian-meal moth and subsequently shown to occur as allergen in various invertebrates and shellfish. The cDNA coding for AK from the house dust mite (HDM) species Dermatophagoides pteronyssinus, Der p 20, has been isolated, but no recombinant Der p 20 (rDer p 20) allergen has been produced and characterized so far. We report the expression of Der p 20 as recombinant protein in Escherichia coli. rDer p 20 was purified and shown to be a monomeric, folded protein by size exclusion chromatography and circular dichroism spectroscopy, respectively. Using AK-specific antibodies, Der p 20 was found to occur mainly in HDM bodies, but not in fecal particles. Thirty percent of clinically well-characterized HDM allergic patients (n = 98) whose immunoglobulin E (IgE) reactivity profiles had been determined with an extensive panel of purified HDM allergens (Der f 1, 2; Der p 1, 2, 4, 5, 7, 10, 11, 14, 15, 18, 21, 23 and 37) showed IgE reactivity to Der p 20. IgE reactivity to Der p 20 was more frequently associated with lung symptoms. AKs were detected in several invertebrates with specific antibodies and Der p 20 showed IgE cross-reactivity with AK from shrimp (Litopenaeus vannamei). Thus, Der p 20 is a cross-reactive HDM allergen and may serve as a diagnostic marker for HDM-induced lung symptoms such as asthma.

11.
Mol Microbiol ; 72(2): 518-36, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19415801

RESUMEN

Infections with the microaerophilic parasite Trichomonas vaginalis are treated with the 5-nitroimidazole drug metronidazole, which is also in use against Entamoeba histolytica, Giardia intestinalis and microaerophilic/anaerobic bacteria. Here we report that in T. vaginalis the flavin enzyme thioredoxin reductase displays nitroreductase activity with nitroimidazoles, including metronidazole, and with the nitrofuran drug furazolidone. Reactive metabolites of metronidazole and other nitroimidazoles form covalent adducts with several proteins that are known or assumed to be associated with thioredoxin-mediated redox regulation, including thioredoxin reductase itself, ribonucleotide reductase, thioredoxin peroxidase and cytosolic malate dehydrogenase. Disulphide reducing activity of thioredoxin reductase was greatly diminished in extracts of metronidazole-treated cells and intracellular non-protein thiol levels were sharply decreased. We generated a highly metronidazole-resistant cell line that displayed only minimal thioredoxin reductase activity, not due to diminished expression of the enzyme but due to the lack of its FAD cofactor. Reduction of free flavins, readily observed in metronidazole-susceptible cells, was also absent in the resistant cells. On the other hand, iron-depleted T. vaginalis cells, expressing only minimal amounts of PFOR and hydrogenosomal malate dehydrogenase, remained fully susceptible to metronidazole. Thus, taken together, our data suggest a flavin-based mechanism of metronidazole activation and thereby challenge the current model of hydrogenosomal activation of nitroimidazole drugs.


Asunto(s)
Antiprotozoarios/metabolismo , Metronidazol/metabolismo , Proteínas Protozoarias/metabolismo , Reductasa de Tiorredoxina-Disulfuro/metabolismo , Trichomonas vaginalis/enzimología , Animales , Antiprotozoarios/farmacología , Células Cultivadas , Resistencia a Medicamentos , Flavinas/metabolismo , Furazolidona/metabolismo , Furazolidona/farmacología , Metronidazol/farmacología , Oxidación-Reducción , Proteómica , Compuestos de Sulfhidrilo/metabolismo , Reductasa de Tiorredoxina-Disulfuro/aislamiento & purificación , Trichomonas vaginalis/efectos de los fármacos
12.
PLoS Biol ; 5(8): e211, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17676992

RESUMEN

Metronidazole, a 5-nitroimidazole drug, has been the gold standard for several decades in the treatment of infections with microaerophilic protist parasites, including Entamoeba histolytica. For activation, the drug must be chemically reduced, but little is known about the targets of the active metabolites. Applying two-dimensional gel electrophoresis and mass spectrometry, we searched for protein targets in E. histolytica. Of all proteins visualized, only five were found to form adducts with metronidazole metabolites: thioredoxin, thioredoxin reductase, superoxide dismutase, purine nucleoside phosphorylase, and a previously unknown protein. Recombinant thioredoxin reductase carrying the modification displayed reduced enzymatic activity. In treated cells, essential non-protein thiols such as free cysteine were also affected by covalent adduct formation, their levels being drastically reduced. Accordingly, addition of cysteine allowed E. histolytica to survive in the presence of otherwise lethal metronidazole concentrations and reduced protein adduct formation. Finally, we discovered that thioredoxin reductase reduces metronidazole and other nitro compounds, suggesting a new model of metronidazole activation in E. histolytica with a central role for thioredoxin reductase. By reducing metronidazole, the enzyme renders itself and associated thiol-containing proteins vulnerable to adduct formation. Because thioredoxin reductase is a ubiquitous enzyme, similar processes could occur in other eukaryotic or prokaryotic organisms.


Asunto(s)
Amebicidas/metabolismo , Entamoeba histolytica/efectos de los fármacos , Entamoeba histolytica/enzimología , Metronidazol/metabolismo , Metronidazol/farmacología , Reductasa de Tiorredoxina-Disulfuro/metabolismo , Amebicidas/química , Amebicidas/farmacología , Amebicidas/uso terapéutico , Secuencia de Aminoácidos , Animales , Células Cultivadas , Cisteína/química , Cisteína/metabolismo , Entamoeba histolytica/citología , Entamebiasis/tratamiento farmacológico , Metronidazol/química , Metronidazol/uso terapéutico , Datos de Secuencia Molecular , Nitroimidazoles/química , Nitroimidazoles/metabolismo , Oxidación-Reducción , Proteínas Protozoarias/química , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , Compuestos de Sulfhidrilo/química , Reductasa de Tiorredoxina-Disulfuro/química , Reductasa de Tiorredoxina-Disulfuro/genética , Tiorredoxinas/química , Tiorredoxinas/genética , Tiorredoxinas/metabolismo
13.
J Antimicrob Chemother ; 64(3): 539-45, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19549672

RESUMEN

OBJECTIVES: Acanthamoebae can cause infections of several organs, including eye, skin, lung and brain. Except for Acanthamoeba keratitis, these infections are linked to immunodeficiency. Treatment is generally problematic, due to the lack of sufficiently effective and also easily manageable drugs. In a previous study we discovered that miltefosine (hexadecylphosphocholine) is highly active against Acanthamoeba spp. in vitro. The aim of the current study was to evaluate the suitability of miltefosine for the topical treatment of Acanthamoeba infections. METHODS: Storage life and time dependency, susceptibilities of opportunistic bacterial and fungal pathogens, and synergistic and adverse effects of combinations with other anti-Acanthamoeba substances were determined. Moreover, an organotypic skin equivalent was adapted for investigating the penetration of acanthamoebae into the epidermis and the human tissue tolerability of miltefosine. RESULTS: It was shown that miltefosine can be stored as a 2 mM stock solution and also as a 50 microM dilution over a period of 12 months at 4 degrees C without any loss of activity. Efficacies against staphylococci and Candida albicans were established. Acanthamoebae were able to penetrate the skin equivalent within 24 h. This penetration was prevented by treatment with miltefosine, while miltefosine treatment was well tolerated by the skin equivalent. CONCLUSIONS: Miltefosine has been approved for oral and topical treatment of leishmaniasis and may also be a promising candidate for the topical treatment of Acanthamoeba infections.


Asunto(s)
Acanthamoeba/efectos de los fármacos , Antiprotozoarios/farmacología , Fosforilcolina/análogos & derivados , Enfermedades de la Piel/parasitología , Animales , Antiprotozoarios/efectos adversos , Antiprotozoarios/farmacocinética , Candida albicans/efectos de los fármacos , Estabilidad de Medicamentos , Almacenaje de Medicamentos , Humanos , Técnicas In Vitro , Fosforilcolina/efectos adversos , Fosforilcolina/farmacocinética , Fosforilcolina/farmacología , Staphylococcus/efectos de los fármacos
14.
Int J Parasitol Drugs Drug Resist ; 10: 109-117, 2019 08.
Artículo en Inglés | MEDLINE | ID: mdl-31472356

RESUMEN

Entamoeba histolytica and Giardia duodenalis are widespread intestinal protozoan parasites which both spread via cysts that have to be ingested to infect a new host. Their environment, the small intestine for G. duodenalis and the colon for E. histolytica, contains only very limited amounts of oxygen, so both parasites generate energy by fermentation and substrate level phosphorylation rather than by oxidative phosphorylation. They both contain reducing agents able to reduce and activate nitroimidazole drugs such as metronidazole which is the gold standard drug to treat Entamoeba or Giardia infections. Although metronidazole works well in the majority of cases, it has a number of drawbacks. In animal models, the drug has carcinogenic activity, and concerns about a possible teratogenic activity remain. In addition, the treatment of G. duodenalis infections is hampered by emerging metronidazole resistance. Plant-derived drugs play a dominant role in human medicine, therefore we tested the activity of 14 isolated plant compounds belonging to seven different classes in vitro against both parasites. The tests were performed in a new setting in microtiter plates under anaerobic conditions. The compound with the highest activity was methylgerambullin, a sulphur-containing amide found in Glycosmis species of the family Rutaceae with an EC50 of 14.5 µM (6.08 µg/ml) after 24 h treatment for E. histolytica and 14.6 µM (6.14 µg/ml) for G. duodenalis. The compound was successfully synthesised in the laboratory which opens the door for the generation of new derivatives with higher activity.


Asunto(s)
Acrilamidas/farmacología , Amidas/farmacología , Antiprotozoarios/farmacología , Entamoeba histolytica/efectos de los fármacos , Giardia lamblia/efectos de los fármacos , Extractos Vegetales/farmacología , Rutaceae/química , Compuestos de Azufre/farmacología , Acrilamidas/síntesis química , Acrilamidas/química , Amidas/síntesis química , Amidas/química , Antiprotozoarios/síntesis química , Antiprotozoarios/química , Entamoeba histolytica/fisiología , Entamebiasis/tratamiento farmacológico , Entamebiasis/parasitología , Giardia lamblia/fisiología , Giardiasis/tratamiento farmacológico , Giardiasis/parasitología , Humanos , Extractos Vegetales/química , Compuestos de Azufre/síntesis química , Compuestos de Azufre/química
15.
Exp Parasitol ; 120(4): 403-10, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18845147

RESUMEN

Entamoeba histolytica remains a cause of significant morbidity and mortality in many countries. Although metronidazole has been used for the treatment of amoebiasis for several decades, little is known on how the amoebae react to this challenge on the levels of mRNA and protein expression. In this study, we examined their response using a focused microarray, quantitative RT-PCR, and two-dimensional gel electrophoresis (2DE). The amoebae modestly increased the levels of mRNA coding for superoxide dismutase, peroxiredoxin, ferredoxin, thioredoxin reductase, and the galactose/N-acetylgalactosamine specific lectin light and heavy chains. The mRNAs encoding actin and the 70kDa and 101kDa heat shock proteins were decreased. All the changes occured within 1h of exposition, with very little further changes. In addition, the proteome revealed only very few changes. Taken together, E. histolytica appears to make only modest mRNA and protein expression changes when confronted with an unknown chemical stress.


Asunto(s)
Antiprotozoarios/farmacología , Entamoeba histolytica/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Metronidazol/farmacología , Proteínas Protozoarias/biosíntesis , ARN Mensajero/biosíntesis , Actinas/biosíntesis , Actinas/genética , Animales , Electroforesis en Gel Bidimensional , Entamoeba histolytica/genética , Entamoeba histolytica/metabolismo , Proteínas HSP70 de Choque Térmico/biosíntesis , Proteínas HSP70 de Choque Térmico/genética , Análisis de Secuencia por Matrices de Oligonucleótidos , Proteoma/biosíntesis , Proteoma/genética , Proteínas Protozoarias/genética , ARN Mensajero/aislamiento & purificación , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Superóxido Dismutasa/biosíntesis , Superóxido Dismutasa/genética , Reductasa de Tiorredoxina-Disulfuro/biosíntesis , Reductasa de Tiorredoxina-Disulfuro/genética , Tiorredoxinas/biosíntesis , Tiorredoxinas/genética
16.
Wien Klin Wochenschr ; 119(19-20 Suppl 3): 88-95, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17987365

RESUMEN

Human amoebiasis caused by Entamoeba histolytica is widely distributed in the tropics and subtropics, but also occurring in neighbouring parts of the temperate zones. Invasive amoebiasis causes dysentery and, by haematogenous spread, also extra-intestinal hepatic, pulmonary or cerebral abscesses, not rarely fatal conditions. The available anti-amoebic drugs have shortcomings regarding tolerability and efficacy. To facilitate the screening of candidate material, an in vitro system has been developed that permits the determination of specific anti-amoebic activity. PYE medium, supplemented with bovine serum, proved to be suitable for the maintenance of the stock cultures of Entamoeba histolytica strain HM1:1MSS. For sensitivity testing, Waymouth medium and cultivation under aerobic conditions were most reliable. After adapting the system to the use of 96-well (8 x 12) tissue culture plates, sensitivity tests were carried out with metronidazole, dehydroemetine and dihydroartemisinin as active control drugs, and seven extracts from Stemona tuberosa, Aglaia edulis, Aglaia elaeagnoidea and Aglaia odorata. Stem bark extract from Aglaia elaeagnoidea was the most active material with an IC(99) of 496 ng/ml and a slope S of 1.1325, followed by leaf extract from Stemona tuberosa with an IC(99) of 638 ng/ml and a slope S of 1.5648. All seven extracts showed full activity at concentrations <4000 ng/ml and qualified for further investigation.


Asunto(s)
Antimaláricos/administración & dosificación , Antimaláricos/clasificación , Antiprotozoarios/administración & dosificación , Antiprotozoarios/farmacocinética , Bioensayo/métodos , Sistemas de Liberación de Medicamentos/métodos , Diseño de Fármacos , Entamoeba histolytica/efectos de los fármacos , Entamoeba histolytica/metabolismo , Relación Dosis-Respuesta a Droga , Tasa de Supervivencia
17.
Wien Klin Wochenschr ; 118(19-20 Suppl 3): 37-41, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17131239

RESUMEN

The microaerophilic protist Entamoeba histolytica is a source of considerable morbidity and mortality in many countries of the world by acting as a causative agent of amoebic dysentery and liver abscess. Its close relative, Entamoeba dispar, also colonises the human colon but is non-pathogenic. In the present study, we wanted to assess if the close relatedness of these two organisms could be used to identify virulence factors in E. histolytica through a comparison of the protein expression profiles of the pathogenic and the non-pathogenic species. We applied two-dimensional polyacrylamide gel electrophoresis in order to identify proteins which are specifically expressed in E. histolytica and which therefore could constitute candidate proteins potentially involved in E. histolytica pathogenicity. The evaluation of overall protein expression profiles derived from whole cell extracts, however, revealed that, in spite of the close relatedness at the genetic level, the disparity of the proteomic profiles of these two Entamoeba species is far too great in order to pinpoint proteins whose expression might render E. histolytica pathogenic. Taken together, our study performed at the proteomic level clearly supports the notion of E. histolytica and E. dispar as two distinct species.


Asunto(s)
Entamoeba histolytica/genética , Entamoeba/genética , Proteínas de Escherichia coli/genética , Proteoma/genética , Proteómica , Animales , Electroforesis en Gel Bidimensional , Entamoeba/patogenicidad , Entamoeba histolytica/patogenicidad , Entamebiasis/parasitología , Humanos , Absceso Hepático Amebiano/parasitología , Espectrometría de Masas , Especificidad de la Especie , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Factores de Virulencia/genética
18.
FASEB J ; 16(3): 414-6, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11790727

RESUMEN

Type I allergy is an immunoglobulin E (IgE)-mediated hypersensitivity disease affecting more than 25% of the population. Currently, diagnosis of allergy is performed by provocation testing and IgE serology using allergen extracts. This process defines allergen-containing sources but cannot identify the disease-eliciting allergenic molecules. We have applied microarray technology to develop a miniaturized allergy test containing 94 purified allergen molecules that represent the most common allergen sources. The allergen microarray allows the determination and monitoring of allergic patients' IgE reactivity profiles to large numbers of disease-causing allergens by using single measurements and minute amounts of serum. This method may change established practice in allergy diagnosis, prevention, and therapy. In addition, microarrayed antigens may be applied to the diagnosis of autoimmune and infectious diseases.


Asunto(s)
Alérgenos/inmunología , Hipersensibilidad Inmediata/diagnóstico , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , Alérgenos/genética , Alérgenos/aislamiento & purificación , Humanos , Hipersensibilidad Inmediata/inmunología , Hipersensibilidad Inmediata/terapia , Inmunoglobulina E/inmunología , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/aislamiento & purificación
19.
PLoS One ; 10(7): e0132623, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26182210

RESUMEN

In Austria, vaccination coverage against Bordetella pertussis infections during infancy is estimated at around 90%. Within the last years, however, the number of pertussis cases has increased steadily, not only in children but also in adolescents and adults, indicating both insufficient herd immunity and vaccine coverage. Waning immunity in the host and/or adaptation of the bacterium to the immunised hosts could contribute to the observed re-emergence of pertussis. In this study we therefore addressed the genetic variability in B. pertussis strains from several Austrian cities. Between the years 2002 and 2008, 110 samples were collected from Vienna (n = 32), Linz (n = 63) and Graz (n = 15) by nasopharyngeal swabs. DNA was extracted from the swabs, and bacterial sequence polymorphisms were examined by MLVA (multiple-locus variable number of tandem repeat analysis) (n = 77), by PCR amplification and conventional Sanger sequencing of the polymorphic regions of the prn (pertactin) gene (n = 110), and by amplification refractory mutation system quantitative PCR (ARMS-qPCR) (n = 110) to directly address polymorphisms in the genes encoding two pertussis toxin subunits (ptxA and ptxB), a fimbrial adhesin (fimD), tracheal colonisation factor (tcfA), and the virulence sensor protein (bvgS). Finally, the ptxP promoter region was screened by ARMS-qPCR for the presence of the ptxP3 allele, which has been associated with elevated production of pertussis toxin. The MLVA analysis revealed the highest level of polymorphisms with an absence of MLVA Type 29, which is found outside Austria. Only Prn subtypes Prn1/7, Prn2 and Prn3 were found with a predominance of the non-vaccine type Prn2. The analysis of the ptxA, ptxB, fimD, tcfA and bvgS polymorphisms showed a genotype mixed between the vaccine strain Tohama I and a clinical isolate from 2006 (L517). The major part of the samples (93%) displayed the ptxP3 allele. The consequences for the vaccination strategy are discussed.


Asunto(s)
Bordetella pertussis/genética , ADN Bacteriano/genética , Programas de Inmunización/organización & administración , Vacuna contra la Tos Ferina/inmunología , Polimorfismo Genético , Tos Ferina/prevención & control , Adolescente , Adulto , Austria/epidemiología , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Técnicas de Tipificación Bacteriana , Secuencia de Bases , Bordetella pertussis/clasificación , Bordetella pertussis/inmunología , Bordetella pertussis/patogenicidad , Niño , Preescolar , ADN Bacteriano/inmunología , ADN Bacteriano/aislamiento & purificación , Femenino , Proteínas Fimbrias/genética , Proteínas Fimbrias/metabolismo , Expresión Génica , Humanos , Lactante , Recién Nacido , Masculino , Datos de Secuencia Molecular , Tipificación de Secuencias Multilocus , Nasofaringe/inmunología , Nasofaringe/microbiología , Toxina del Pertussis/genética , Toxina del Pertussis/metabolismo , Vacuna contra la Tos Ferina/administración & dosificación , Subunidades de Proteína/genética , Subunidades de Proteína/metabolismo , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Vacunación , Factores de Virulencia de Bordetella/genética , Factores de Virulencia de Bordetella/metabolismo , Tos Ferina/epidemiología , Tos Ferina/inmunología , Tos Ferina/microbiología
20.
Mol Biochem Parasitol ; 126(2): 165-72, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12615315

RESUMEN

The antiprotozoal activity of phospholipid analogues, originally developed as anti-cancer drugs, has been determined in the past decade. The most susceptible parasites are Leishmania spp. and Trypanosoma cruzi with activity also shown against Trypanosoma brucei spp., Entamoeba histolytica and Acanthamoeba spp. Miltefosine, an alkylphosphocholine, was registered for the oral treatment of visceral leishmaniasis (VL) in India in March 2002. This review will focus on the biological activities of phospholipid analogues. Biochemical and molecular targets and mechanism(s) of action have been studied extensively in tumor cells but have not been determined in protozoa.


Asunto(s)
Antiprotozoarios/farmacología , Fosfolípidos/farmacología , Fosforilcolina/análogos & derivados , Animales , Antiprotozoarios/química , Antiprotozoarios/uso terapéutico , Leishmania/efectos de los fármacos , Pruebas de Sensibilidad Parasitaria , Éteres Fosfolípidos/química , Éteres Fosfolípidos/farmacología , Fosfolípidos/química , Fosfolípidos/uso terapéutico , Fosforilcolina/química , Fosforilcolina/farmacología , Relación Estructura-Actividad , Trypanosoma/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA